ArticleBMC women's health2025
Symptom experiences of cancer-related cognitive impairment in women with ovarian cancer.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCancer-related cognitive impairment (CRCI) is one of the most prevalent and persistent symptoms reported by women with ovarian cancer. This study aims to comprehensively explore the symptom experience of CRCI in people/women with ovarian cancer.
methodsSemi-structured interviews were conducted with eligible people/women with ovarian cancer in Cancer Center of Fudan University, Shanghai, China. The interview guide and data coding were developed based on the symptom management theory. Qualitative content analysis was utilized to identify and refine key themes and sub-themes.
resultsThe study included 31 participants with a mean age of 51.38 years (range: 25-65 years) and a median time since diagnosis of one year (range: 0.35-14.2 years). Four themes and ten sub-themes were identified: Theme 1 CRCI Perception, including two subthemes: 'Experiencing subtle cognitive decline' and 'No feeling or no opportunity to feel the changes in cognitive function'. Theme 2 CRCI Attribution, including three subthemes: 'social disengagement and values reconstruction' 'symptom entanglement' and 'surgical anesthesia and chemotherapy'. Theme 3 CRCI Impacts: 'contained life disruption' and 'eroded self-efficacy'. Theme 4 Adaptive responses: 'cognitive load reduction' 'Compensatory strategies' and 'Passive acceptance'.
conclusionsThe majority of women with ovarian cancer in this study reported experiencing CRCI, primarily characterized by memory and attention deficits. Sociocultural context and individual cancer copying style played an important role on the CRCI symptom experience, underscoring the need for culturally sensitive, patient-centered interventions to address CRCI in ovarian cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.